Overview
Portfolio
More
Mutual Capital Partners
Westlake, United States
Focus on software, medical device, and healthcare IT companies, emphasizing strong management and leveraging a network of investors for due diligence, introductions, and ongoing support.
Portfolio
12+
Employees
5+
Founded
2004
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Fund details
Funds
Mutual Capital Partners Fund IV
Vintage 2023
Mutual Capital Partners Fund I
Vintage 2005
MCPF III Opportunity Fund
MCPF II
$30.0M
Mutual Capital Partners Fund III
Sources
Mutual Capital Partners
Focus on software, medical device, and healthcare IT companies, emphasizing strong management and leveraging a network of investors for due diligence, introductions, and ongoing support.
Portfolio
12+
Employees
5+
Founded
2004
AUM
N/A
Funds
Mutual Capital Partners Fund IV · Vintage 2023
Mutual Capital Partners Fund I · Vintage 2005
MCPF III Opportunity Fund
MCPF II · $30.0M
Mutual Capital Partners Fund III
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 8 of 8 matched portfolio companies
7SIGNAL offers an AI‑driven platform that continuously monitors Wi‑Fi spectrum, client devices, and application performance across enterprise environments. By applying machine‑learning models to real‑time data, it provides automated root‑cause analysis and remediation recommendations through dashboards and ITSM integrations, helping large organizations reduce unplanned downtime and improve wireless connectivity.
Authenticx provides a centralized analytics platform that processes diverse customer interactions, such as calls and texts, using proprietary AI models tailored for healthcare. This technology enables organizations to identify compliance events, enhance operational efficiency, and improve patient outcomes by transforming conversational data into actionable insights.
Funding: $32.4M
Rough estimate of the amount of funding raised
Funding: $32.4M
Rough estimate of the amount of funding raised
Cooler Heads has developed Amma™, a portable scalp cooling system that lowers scalp temperature during chemotherapy to reduce hair loss by limiting the absorption of chemotherapy drugs in hair follicles. This FDA-cleared device allows patients to self-administer treatment anywhere in the infusion center, providing a practical solution for maintaining their identity and mental well-being during cancer treatment.
Funding: $34.6M
Rough estimate of the amount of funding raised
Funding: $34.6M
Rough estimate of the amount of funding raised
Elevation Spine develops the SABER-C cervical fusion system, which features a zero-profile anterior cervical plate and low-profile fixation options for minimally invasive spinal surgery. This technology enables surgeons to perform spinal fusion more efficiently through smaller incisions, improving access to challenging cervical spine levels while reducing recovery time for patients.
Funding: $13.0M
Rough estimate of the amount of funding raised
Funding: $13.0M
Rough estimate of the amount of funding raised
enosix provides real-time data integration solutions that connect SAP systems with front-end applications like Salesforce and ServiceNow, enabling seamless access to accurate pricing and inventory information. This technology eliminates manual processes and data discrepancies, significantly improving operational efficiency and reducing costs for businesses transitioning from SAP ECC to S/4HANA.
IotaMotion develops the iotaSOFT® Insertion System, a robotic-assisted platform that standardizes cochlear implant electrode array insertion to minimize surgical variability. This technology addresses the challenges of high insertion forces and variability, reducing maximum insertion force by 51% and force variation by 78%, thereby enhancing patient safety and surgical outcomes.
Funding: $25.9M
Rough estimate of the amount of funding raised
Funding: $25.9M
Rough estimate of the amount of funding raised
Olio is a collaboration platform that connects acute and post-acute healthcare providers by specialty, facilitating streamlined communication and care coordination. This integration addresses the fragmentation in patient management, improving continuity of care and operational efficiency across healthcare settings.
Funding: $17.5M
Rough estimate of the amount of funding raised
Funding: $17.5M
Rough estimate of the amount of funding raised
Redi Health connects pharmaceutical manufacturers directly to patients to improve medication adherence and sustainment across therapy journeys. The platform provides targeted strategies to enhance patient acquisition and support for life sciences companies. This results in better patient outcomes while allowing clinical teams to focus on direct care.
Funding: $19.0M
Rough estimate of the amount of funding raised
Funding: $19.0M
Rough estimate of the amount of funding raised
Showing 4 of 4 unmatched portfolio companies